Mulligan Richard — SEC Form 4 filings
SEC reporting owner CIK 1376247. 11 Form 4 filings on record with FilingPulse; latest filed 2026-06-05.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-05-20 to 2026-06-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 300,000 shares, $1,195,740 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 150,000 shares @ $4.08 ($612,570) in Sana Biotechnology, Inc., filed 2024-09-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Sana Biotechnology, Inc. (SANA) | Director | 5 | — | 2 legs · 300,000 sh · $1,195,740 | 4 |
| INTERNATIONAL FLAVORS & FRAGRANCES INC (IFF) | Director | 3 | — | — | 4 |
| Bausch Health Companies Inc. (BHC) | Director | 3 | — | — | 2 |
Form 4 filings — Mulligan Richard
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-05 | 4 | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | INTERNATIONAL FLAVORS & FRAGRANCES INC (IFF) | Option exercise (M): 1,712 @ $0 · Option exercise (M): 1,712 (derivative) @ $70.81 | EDGAR |
| 2026-04-30 | 4 | INTERNATIONAL FLAVORS & FRAGRANCES INC (IFF) | Grant/award (A): 2,903 (derivative) @ $0 | EDGAR |
| 2025-11-04 | 4 | INTERNATIONAL FLAVORS & FRAGRANCES INC (IFF) | Grant/award (A): 1,712 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2025-05-20 | 4 | Bausch Health Companies Inc. (BHC) | Grant/award (A): 54,347 @ $0 | EDGAR |
| 2024-09-26 | 4 | Sana Biotechnology, Inc. (SANA) | Sale (S): 150,000 @ $4.08 · Sale (S): 150,000 @ $3.89 | EDGAR |
| 2024-07-15 | 4/A | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 54,278 (derivative) @ $0 | EDGAR |
| 2024-05-21 | 4/A | Bausch Health Companies Inc. (BHC) | Holdings only — no transactions reported | EDGAR |
| 2024-05-20 | 4/A | Bausch Health Companies Inc. (BHC) | Grant/award (A): 35,360 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1376247 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →